Exclusive: FibroBiologics moves forward with human trial for diabetic foot ulcer therapy

FibroBiologics Inc. FBLG on Tuesday said it completed manufacturing of the first batch of FibroBiologics' proprietary CYWC628 ...
The Manila Times

FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial

FibroBiologics, Inc., (Nasdaq: FBLG) ('FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

AIROS Medical Appoints Dr. John Evans as Lead Medical Advisor

AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy systems that treat peripheral ...
Opinion

Mölnlycke: Europe faces a growing chronic wound crisis - time to act is now

Mölnlycke, a global leader in MedTech, today welcomes the publication of Shaping the future of wound care in Europe, the first joint industry ...